Rachid Berair

Rachid Berair

Auto-generated profile, based on publicly available information

Rachid Berair

Institute for Lung Health, NIHR Respiratory Biomedical Research Unit, Dept of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
SGSherif Gonem
Sherif Gonem
RBRachid Berair
Rachid Berair
ASAmisha Singapuri
Amisha Singapuri
RHRuth Hartley
Ruth Hartley
MLMarie F M Laurencin
Marie F M Laurencin
CBChristopher E Brightling
Christopher E Brightling

16 March 2015 in Allergy
Verified
Journal Article
Open access
PDF file
DKDavinder Kaur
Davinder Kaur
EGEdith Gomez
Edith Gomez
CDCamille Doe
Camille Doe
RBRachid Berair
Rachid Berair
LWLucy Woodman
Lucy Woodman
CBChristopher Brightling
Christopher Brightling
Background: Mast cell localization within the airway smooth muscle (ASM)‐bundle plays an important role in the development of airway hyper‐responsiveness (AHR). Genomewide association studies implicate the ‘alarmin’ IL‐33 in asthma, but its role in mast cell–ASM interactions is unknown.Objectives: We examined the expression and functional role of IL‐33 in bronchial biopsies of patients with and without asthma, ex vivo ASM, mast cells, cocultured cells and in a mouse model system.Methods: IL‐33 protein expression was assessed in human bronchial tissue from 9 healthy controls, and 18 mild‐to‐moderate and 12 severe asthmatic patients by immunohistochemistry. IL‐33 and ST2 mRNA and protein expression in human‐derived ASM, epithelial and mast cells were assessed by qPCR, immunofluorescence and/or flow cytometry and ELISA. Functional assays were used to assess calcium signalling, wound repair, proliferation, apoptosis and contraction. AHR and inflammation were assessed in a mouse model.Results: Bronchial epithelium and ASM expressed IL‐33 with the latter in asthma correlating with AHR. ASM and mast cells expressed intracellular IL‐33 and ST2. IL‐33 stimulated mast cell IL‐13 and histamine secretion independent of FcεR1 cross‐linking and directly promoted ASM wound repair. Coculture of mast cells with ASM activated by IL‐33 increased agonist‐induced ASM contraction, and in vivo IL‐33 induced AHR in a mouse cytokine installation model; both effects were IL‐13 dependent.Conclusion: IL‐33 directly promotes mast cell activation and ASM wound repair but indirectly promotes ASM contraction via upregulation of mast cell‐derived IL‐13. This suggests that IL‐33 may present an important target to modulate mast cell–ASM crosstalk in asthma.

24 July 2014 in Drugs
Verified
Journal Article
Closed access
PDF file
RBRachid Berair
Rachid Berair
CBChristopher E. Brightling
Christopher E. Brightling

6 June 2013 in BMC Medicine
Verified
Journal Article
Open access
PDF file
RBRachid Berair
Rachid Berair
RSRuth Saunders
Ruth Saunders
CBChristopher E Brightling
Christopher E Brightling
Asthma is characterized by both chronic inflammation and airway remodeling. Remodeling - the structural changes seen in asthmatic airways - is pivotal in the pathogenesis of the disease. Although significant advances have been made recently in understanding the different aspects of airway remodeling, the exact biology governing these changes remains poorly understood. There is broad agreement that, in asthma, increased airway smooth muscle mass, in part due to smooth muscle hyperplasia, is a very significant component of airway remodeling. However, significant debate persists on the origins of these airway smooth muscle cells. In this review article we will explore the natural history of airway remodeling in asthma and we will discuss the possible contribution of progenitors, stem cells and epithelial cells in mesenchymal cell changes, namely airway smooth muscle hyperplasia seen in the asthmatic airways.

19 July 2016 in Respiratory Research
Verified
Journal Article
Open access
PDF file
FHFay Hollins
Fay Hollins
ASAmanda Sutcliffe
Amanda Sutcliffe
EGEdith Gomez
Edith Gomez
RBRachid Berair
Rachid Berair
RRRichard Russell
Richard Russell
CBChristopher Brightling
Christopher Brightling
The burden of oxidative stress is increased in chronic obstructive pulmonary disease (COPD). However, whether the intra-cellular mechanisms controlling the oxidant/anti-oxidant balance in structural airway cells such as airway smooth muscle in COPD is altered is unclear. We sought to determine whether the expression of the NADPH oxidase (NOX)-4 is increased in airway smooth muscle in COPD both in vivo and primary cells in vitro and its role in hydrogen peroxide-induced reactive oxygen species generation. We found that in vivo NOX4 expression was up-regulated in the airway smooth muscle bundle in COPD (n = 9) and healthy controls with >20 pack year history (n = 4) compared to control subjects without a significant smoking history (n = 6). In vitro NOX4 expression was increased in airway smooth muscle cells from subjects with COPD (n = 5) compared to asthma (n = 7) and upregulated following TNF-α stimulation. Hydrogen peroxide-induced reactive oxygen species generation by airway smooth muscle cells in COPD (n = 5) was comparable to healthy controls (n = 9) but lower than asthma (n = 5); and was markedly attenuated by NOX4 inhibition. Our findings demonstrate that NOX4 expression is increased in vivo and in vitro in COPD and although we did not observe an intrinsic increase in oxidant-induced reactive oxygen species generation in COPD, it was reduced markedly by NOX4 inhibition supporting a potential therapeutic role for NOX4 in COPD.

1 May 2017 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
RBRachid Berair
Rachid Berair
RHRuth Hartley
Ruth Hartley
VMVijay Mistry
Vijay Mistry
ASAjay Sheshadri
Ajay Sheshadri
SGSumit Gupta
Sumit Gupta
CBChristopher E. Brightling
Christopher E. Brightling
Airway remodelling in asthma remains poorly understood. This study aimed to determine the association of airway remodelling measured on bronchial biopsies with 1) lung function impairment and 2) thoracic quantitative computed tomography (QCT)-derived morphometry and densitometry measures of proximal airway remodelling and air trapping.Subjects were recruited from a single centre. Bronchial biopsy remodelling features that were the strongest predictors of lung function impairment and QCT-derived proximal airway morphometry and air trapping markers were determined by stepwise multiple regression. The best predictor of air trapping was validated in an independent replication group.Airway smooth muscle % was the only predictor of post-bronchodilator forced expiratory volume in 1 s (FEV1) % pred, while both airway smooth muscle % and vascularity were predictors of FEV1/forced vital capacity. Epithelial thickness and airway smooth muscle % were predictors of mean segmental bronchial luminal area (R2=0.12; p=0.02 and R2=0.12; p=0.015), whereas epithelial thickness was the only predictor of wall area % (R2=0.13; p=0.018). Vascularity was the only significant predictor of air trapping (R2=0.24; p=0.001), which was validated in the replication group (R2=0.19; p=0.031).In asthma, airway smooth muscle content and vascularity were both associated with airflow obstruction. QCT-derived proximal airway morphometry was most strongly associated with epithelial thickness and airway smooth muscle content, whereas air trapping was related to vascularity.